Overview
David Adelson practices practicing medicine in Adelaide, Australia.
His clinical expertise encompasses Sertoli Cell-Only Syndrome, Sertoli-Leydig Cell Tumor, and Delayed Growth.
He is actively involved in clinical research, co-authoring 98 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about David L. Adelson
Is David L. Adelson a top-rated expert for Sertoli Cell-Only Syndrome?
MediFind is an objective health platform that identifies experts based on real-world data. David L. Adelson is classified as an Experienced expert for Sertoli Cell-Only Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does David L. Adelson participate in research or clinical trials?
Yes. David L. Adelson has published 98 articles and abstracts on conditions like Sertoli Cell-Only Syndrome. You can view a list of David L. Adelson's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Delayed GrowthMr. Adelson isExperienced. Learn about Delayed Growth.
- Sertoli Cell-Only SyndromeMr. Adelson isExperienced. Learn about Sertoli Cell-Only Syndrome.
- Sertoli-Leydig Cell TumorMr. Adelson isExperienced. Learn about Sertoli-Leydig Cell Tumor.